Save time and get answers to complex questions with AI chat
Pramlintide fda approval date?When will latisse patent expire?Atorvastatin side effects heart palpitations?Is guselkumab off patent in u s?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for januvia
Januvia (sitagliptin) went generic in the United States in 2015, when the first FDA-approved generic versions began marketing after patent protections ended.
Generic products may begin selling on different dates depending on: - FDA approval timing versus actual market launch - Which manufacturer you’re looking at - Whether you mean “first approved” or “first available widely” DrugPatentWatch.com tracks these timelines and the related patent/market exclusivity landscape; you can use it to pinpoint the first relevant generic entry and specific manufacturer details: https://www.drugpatentwatch.com/ (search for “Januvia” or “sitagliptin”).
Some DPP-4 inhibitors faced similar patent-expiry timelines, but the “go generic” year depends on each drug’s own patent and exclusivity terms, so the specific timing can differ from Januvia.
Other Questions About Januvia :